Difamilast (Adquey)

What is difamilast?

Difamilast (Adquey) is a nonsteroidal topical medication used for atopic dermatitis. It is part of the topical PDE4 inhibitor class and offers another steroid-free option for patients with mild-to-moderate eczema.

It may be especially useful for patients who want to limit topical steroid exposure, need treatment for more sensitive body areas, or are looking for another option after irritation or incomplete response with other topicals.

How does difamilast work?

Difamilast works by blocking phosphodiesterase-4, usually shortened to PDE4. This reduces inflammatory signaling in the skin and can help calm redness, itching, and eczema activity.

It is in the same broad family as other PDE4 inhibitors used in dermatology, but it gives another formulation choice within that class.

What are possible side effects of difamilast?

Possible side effects can include:

  • Application-site burning or stinging

  • Redness or irritation

  • Itching in treated areas

  • Discomfort early in treatment in some patients

As with other topical eczema medications, these reactions are often most noticeable when the skin is very inflamed at baseline.

How is difamilast used?

Difamilast is applied to affected skin as directed by your provider. It is generally discussed as a steroid-free option for mild-to-moderate eczema and may be used as part of a broader skin-care plan that also includes moisturization and trigger reduction.

For many patients, the main question is not whether it replaces every other eczema treatment, but where it fits among topical steroids, calcineurin inhibitors, ruxolitinib, tapinarof, and other steroid-free options.

THIS CONTENT IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES AND MAY NOT BE COMPREHENSIVE. IT DOES NOT CONSTITUTE MEDICAL ADVICE. PLEASE REFER TO OUR TERMS OF USE FOR FURTHER DETAILS. ALWAYS CONSULT WITH YOUR HEALTHCARE PROVIDER BEFORE MAKING ANY MEDICAL DECISIONS.